Importantly, a lower content of CD44-expressing cells was observed in metformin-treated xenografts than in untreated tumors (Figure 6b), although a precise quantification was not possible due to the heterogeneous presence of these cells within the tumor mass (see also comments to data reported in Figure 1). Here, CD44 is linked to neoplasm.